Form 4: Nukkleus Director Receives 5,000 Stock Grant
Insider Transaction Report
Nukkleus Inc. Director Aviya Volodarsky was granted 5,000 shares of common stock under the company's 2025 Equity Incentive Plan.
Summary
- Aviya Volodarsky, a Director of Nukkleus Inc., acquired 5,000 shares of common stock.
- The shares were issued on November 13, 2025, under the Company's 2025 Equity Incentive Plan.
- The grant was in consideration of services rendered to the Company.
- Following this transaction, Aviya Volodarsky beneficially owns 15,000 shares of Nukkleus Inc. common stock.
Sentiment
Score: 6
Explanation: Slightly positive as it indicates ongoing director compensation and alignment of interests, but it's a routine filing with no significant market impact.
Positives
- The grant aligns the director's interests with shareholders through equity ownership.
- Issuance under an Equity Incentive Plan is a standard practice for director compensation.
Industry Context
This is a routine insider transaction filing, common across all industries, reflecting standard compensation practices for corporate directors through equity incentive plans.
Comparison to Industry Standards
- The grant of equity to directors as part of their compensation package is a widely accepted practice across public companies, including those in the financial technology sector where Nukkleus Inc. operates.
- This aligns director incentives with long-term shareholder value, a common governance principle.
- Specific comparable companies or projects are not detailed in this filing, but such grants are standard for directors at companies of similar market capitalization and stage.
Related Party Transactions
- The grant of 5,000 shares to Aviya Volodarsky, a director, under the company's equity incentive plan constitutes a related party transaction as it involves compensation to an insider.
Stakeholder Impact
- Shareholders: Minor dilution from the issuance of new shares, but also potential benefit from increased director alignment with company performance.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Date of transaction where 5,000 shares were acquired. |
| 11/20/2025 | Date the Form 4 was signed by the reporting person. |
Keywords
Nukkleus Inc., NUKK, Form 4, Insider Transaction, Stock Grant, Equity Incentive Plan, Director Compensation, Aviya Volodarsky
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.